COMPOUNDING

Asymmetric Value Creation

Global Insurance Group — High-Growth Markets  |  €1B+ IT spend | Emerging and high-growth regions | 2011–2013

Context & Stakes

A global insurance group with over €1B in annual IT spend was operating across high-growth markets. Innovation was defined as vendor-led upgrades. There was no organizational capability to credibly challenge incumbent vendors.

The Real Problem (Not the Stated One)

They Thought

Innovation means vendor-led upgrades, local experimentation, incremental improvements layered onto enterprise platforms.

My Findings

Enterprise tools were vastly over-engineered for actual needs. The group lacked a safe, global experimentation capability able to challenge incumbent vendors credibly. Without a credible alternative, the organization had no negotiating leverage.

Key Interventions

Measured Outcomes

The credible alternative shifted vendor economics. Approximately €9M in recurring annual savings from renegotiated per-user licensing across multiple regions.

To be precise: the €10k experiment did not “create” €9M. It removed the organization’s lack of leverage. The value came from changed bargaining power — the same logic as qualifying a second supplier in a concentrated market.

Second-Order Effects

Strategic optionality: The organization permanently gained the ability to challenge vendor economics.

Culture shift: Innovation was repositioned from “exploring ideas” to “creating economic weapons.”

Why This Case Is Reusable

Any organization with significant vendor concentration and no credible alternative is likely overpaying structurally. The pattern applies wherever procurement optionality is absent.

If this resembles your situation, I'm available for a confidential conversation.

eric.de.morgoli@proton.me   or   View engagement criteria